Pharmacological treatment of schizophrenia with comorbid substance use disorder.

about

Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders.

P2860

Q47274758-BCB8DFA8-7B64-4427-B48B-E3C0250E0DAC

P2860

Pharmacological treatment of schizophrenia with comorbid substance use disorder.

Item

http://www.wikidata.org/entity/Q38658672

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Pharmacological treatment of schizophrenia with comorbid substance use disorder.

@en

type

Item

label

Pharmacological treatment of schizophrenia with comorbid substance use disorder.

@en

prefLabel

Pharmacological treatment of schizophrenia with comorbid substance use disorder.

@en

P1476

Pharmacological treatment of schizophrenia with comorbid substance use disorder

@en

P2093

Jean-Michel Azorin

http://www.w3.org/2001/XMLSchema#string

Marc Adida

http://www.w3.org/2001/XMLSchema#string

Raoul Belzeaux

http://www.w3.org/2001/XMLSchema#string

P2860

Cochrane Database of Systematic Reviews

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study

A neurobiological basis for substance abuse comorbidity in schizophrenia

A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients

Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia.

Significant interaction between clozapine and cocaine in cocaine addicts.

The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis.

Effects of antipsychotics on brain structure.

P304

231-253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2016.1114101

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nicolas Simon

P577

2015-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26635059

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

Pharmacological treatment of schizophrenia with comorbid substance use disorder.

about

P2860

P2860

Pharmacological treatment of schizophrenia with comorbid substance use disorder.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921